FUSED HETEROCYCLIC INDANE CARBOXAMIDE CGRP RECEPTOR ANTAGONISTS
    9.
    发明申请
    FUSED HETEROCYCLIC INDANE CARBOXAMIDE CGRP RECEPTOR ANTAGONISTS 有权
    融合杂环氨基羧酰胺CGRP受体拮抗剂

    公开(公告)号:US20130261138A1

    公开(公告)日:2013-10-03

    申请号:US13994905

    申请日:2011-12-16

    IPC分类号: C07D487/04 C07D471/04

    摘要: The present invention is directed to fused heterocyclic indane carboxamide derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

    摘要翻译: 本发明涉及作为CGRP受体拮抗剂的稠合杂环吲哚甲酰胺衍生物,可用于治疗或预防涉及CGRP的疾病,如偏头痛。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及CGRP的疾病中的用途。